mRNA expression of muscarinic receptors in spinal cord and brainstem in morphine dependent rats

To observe mRNA expression of muscarinic acetylcholine receptors in spinal cord and brainstem in morphine dependent or withdrawal rats. The mRNA expression level of m1, m2, m3, m4 and m5 were determined by RT-PCR, the beta-actin mRNA expression was used as internal control. The mRNA level of m1, m2,...

Full description

Saved in:
Bibliographic Details
Published inYao hsüeh hsüeh pao Vol. 37; no. 8; p. 611
Main Authors Zhou, Wen-hua, Liu, Hui-fen, Gu, Jun, Xie, Xiao-hu, Tang, Shuai-en, Yang, Guo-dong, Wu, Qi-xia
Format Journal Article
LanguageChinese
Published China 01.08.2002
Subjects
Online AccessGet more information

Cover

Loading…
More Information
Summary:To observe mRNA expression of muscarinic acetylcholine receptors in spinal cord and brainstem in morphine dependent or withdrawal rats. The mRNA expression level of m1, m2, m3, m4 and m5 were determined by RT-PCR, the beta-actin mRNA expression was used as internal control. The mRNA level of m1, m2, m3, m4 and m5 in spinal cord and m1 and m2 in brainstem were increased significantly during morphine dependence, and the levels of m1, m2, m3 and m4 in spinal cord and m1 in brainstem were decreased 1 h after the injection of naloxone (4 mg.kg-1, i.p.) in morphine dependent rats. Either scopolamine (0.5 mg.kg-1) or pirenzepine (10 mg.kg-1) was shown to significantly decrease the morphine withdrawal symptoms in rats. The levels of m1, m2, m3 and m5 in spinal cord were increased by pretreatment with pirenzepine and the levels of m2, m3 and m4 in spinal cord were increased by pretreatment with scopolamine. The adaptive expression of muscarinic receptors at spinal and supraspinal levels play important role in mediatin
ISSN:0513-4870